{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:30:37Z","timestamp":1793154637020,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77296-8","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:20:06Z","timestamp":1730107206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Survival benefit added by adjuvant chemotherapy in adenoid cystic carcinoma of salivary gland"],"prefix":"10.1038","volume":"14","author":[{"given":"Ning","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"77296_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11864-022-01043-2","volume":"24","author":"AJ Kacew","year":"2023","unstructured":"Kacew, A. J. & Hanna, G. J. Systemic and targeted therapies in Adenoid cystic carcinoma. Curr. Treat. Options Oncol. 24, 45\u201360 (2023).","journal-title":"Curr. Treat. Options Oncol."},{"key":"77296_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.21873\/anticanres.16929","volume":"44","author":"M Zupancic","year":"2024","unstructured":"Zupancic, M., N\u00e4sman, A., Friesland, S. & Dalianis, T. Adenoid Cystic Carcinoma, clinical presentation, current treatment and approaches towards Novel therapies. Anticancer Res. 44, 1325\u20131334 (2024).","journal-title":"Anticancer Res."},{"key":"77296_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell, J. J. et al. NCCN Guidelines\u00ae insights: Head and Neck cancers, Version 1.2022. J. Natl. Compr. Canc Netw. 20, 224\u2013234 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"77296_CR4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","volume":"39","author":"JL Geiger","year":"2021","unstructured":"Geiger, J. L. et al. Management of salivary gland malignancy: ASCO Guideline. J. Clin. Oncol. 39, 1909\u20131941 (2021).","journal-title":"J. Clin. Oncol."},{"key":"77296_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00066-021-01833-x","volume":"198","author":"J von der Gr\u00fcn","year":"2022","unstructured":"von der Gr\u00fcn, J. et al. Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice. Strahlenther Onkol. 198, 123\u2013134 (2022).","journal-title":"Strahlenther Onkol"},{"key":"77296_CR6","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier, J. et al. European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl. J. Med. 350, 1945\u20131952 (2004).","journal-title":"N Engl. J. Med."},{"key":"77296_CR7","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper, J. S. et al. Radiation Therapy Oncology Group 9501\/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl. J. Med. 350, 1937\u20131944 (2004).","journal-title":"N Engl. J. Med."},{"key":"77296_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","volume":"27","author":"J Bernier","year":"2005","unstructured":"Bernier, J. et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 27, 843\u2013850 (2005).","journal-title":"Head Neck"},{"key":"77296_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.anorl.2015.09.009","volume":"133","author":"M Meyers","year":"2016","unstructured":"Meyers, M. et al. REFCOR members. Head and neck adenoid cystic carcinoma: a prospective multicenter REFCOR study of 95 cases. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 133, 13\u201317 (2016).","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"77296_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00432-024-05719-0","volume":"150","author":"Z Qiu","year":"2024","unstructured":"Qiu, Z. et al. Platinum-based adjuvant chemoradiotherapy versus adjuvant radiotherapy in patients with head and neck adenoid cystic carcinoma. J. Cancer Res. Clin. Oncol. 150, 195 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"77296_CR11","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/hed.27676","volume":"46","author":"Q Fang","year":"2024","unstructured":"Fang, Q. et al. Neck management in cutaneous squamous cell carcinoma with parotid metastasis. Head Neck. 46, 1938\u20131945 (2024).","journal-title":"Head Neck"},{"key":"77296_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13014-024-02495-6","volume":"19","author":"DH Schanne","year":"2024","unstructured":"Schanne, D. H., Alder, D. U., Lippmann, J., Aebersold, D. M. & Elicin, O. Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma. Radiat. Oncol. 19, 104 (2024).","journal-title":"Radiat. Oncol."},{"key":"77296_CR13","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","volume":"83","author":"R Little","year":"1988","unstructured":"Little, R. A test of missing completely at random for multivariable data with missing values. J. Am. Stat. Assoc. 83, 1198\u20131202 (1988).","journal-title":"J. Am. Stat. Assoc."},{"key":"77296_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0962280206074463","volume":"16","author":"S van Buuren","year":"2007","unstructured":"van Buuren, S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat. Methods Med. Res. 16, 219\u2013242 (2007).","journal-title":"Stat. Methods Med. Res."},{"key":"77296_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12070-023-04104-6","volume":"76","author":"K Bhushan","year":"2024","unstructured":"Bhushan, K., Sharma, M. L. & Gupta, D. K. Chemotherapy for salivary gland malignant carcinoma: Meta-analysis and systemic review. Indian J. Otolaryngol. Head Neck Surg. 76, 123\u2013129 (2024).","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"77296_CR16","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jamaoto.2016.2168","volume":"142","author":"A Amini","year":"2016","unstructured":"Amini, A. et al. Association of Adjuvant Chemoradiotherapy vs Radiotherapy alone with survival in patients with resected major salivary gland carcinoma: data from the National Cancer Data Base. JAMA Otolaryngol. Head Neck Surg. 142, 1100\u20131110 (2016).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"77296_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/hed.24984","volume":"40","author":"S Cheraghlou","year":"2018","unstructured":"Cheraghlou, S. et al. Adjuvant therapy in major salivary gland cancers: analysis of 8580 patients in the National Cancer Database. Head Neck. 40, 1343\u20131355 (2018).","journal-title":"Head Neck"},{"key":"77296_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hed.27222","volume":"45","author":"AJ Gordon","year":"2023","unstructured":"Gordon, A. J. et al. Adoption of adjuvant chemotherapy in high-risk salivary gland malignancies. Head Neck. 45, 167\u2013177 (2023).","journal-title":"Head Neck"},{"key":"77296_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/0194599819827851","volume":"160","author":"K Aro","year":"2019","unstructured":"Aro, K. et al. Survival impact of adjuvant therapy in Salivary Gland Cancers following Resection and Neck Dissection. Otolaryngol. Head Neck Surg. 160, 1048\u20131057 (2019).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"77296_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13014-016-0617-7","volume":"11","author":"CE Hsieh","year":"2016","unstructured":"Hsieh, C. E. et al. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study. Radiat. Oncol. 11, 47 (2016).","journal-title":"Radiat. Oncol."},{"key":"77296_CR21","doi-asserted-by":"publisher","first-page":"106491","DOI":"10.1016\/j.oraloncology.2023.106491","volume":"145","author":"H Shimoda","year":"2023","unstructured":"Shimoda, H. et al. Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis. Oral Oncol. 145, 106491 (2023).","journal-title":"Oral Oncol."},{"key":"77296_CR22","doi-asserted-by":"publisher","first-page":"1153186","DOI":"10.3389\/fonc.2023.1153186","volume":"13","author":"F Han","year":"2023","unstructured":"Han, F. Number of positive lymph nodes affects outcomes in parotid adenoid cystic carcinoma. Front. Oncol. 13, 1153186 (2023).","journal-title":"Front. Oncol."},{"key":"77296_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/annonc\/mdy490","volume":"30","author":"ZS Zumsteg","year":"2019","unstructured":"Zumsteg, Z. S. et al. Quantitative lymph node burden as a \u2018very-high-risk\u2019 factor identifying head and neck cancer patients benefiting from postoperative chemoradiation. Ann. Oncol. 30, 76\u201384 (2019).","journal-title":"Ann. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77296-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:36:57Z","timestamp":1730108217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77296-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77296"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77296-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"26 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Henan Cancer Hospital Institutional Research Committee, and written informed consent for medical research was obtained from all patients prior to initial treatment. All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations of interest"}}],"article-number":"25746"}}